Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs.

BMC Urology
Yao-Chi ChuangMichael B Chancellor

Abstract

With the increasing interest with botulinum toxin--A (BTX-A) application in the lower urinary tract, we investigated the BTX-A effects on the canine prostate and also in men with bladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH). Transperineal injection into the prostate using transrectal ultrasound (TRUS) was performed throughout the study. Saline with or without 100 U of BTX-A was injected into mongrel dogs prostate. One or 3 months later, the prostate was harvested for morphologic and apoptotic study. In addition, eight BPH patients refractory to alpha-blockers were treated with ultrasound guided intraprostatic injection of 200 U of BTX-A. In the BTX-A treated dogs, atrophy and diffuse apoptosis was observed with H&E stain and TUNEL stain at 1 and 3 months. Clinically, the mean prostate volume, symptom score, and quality of life index were significantly reduced by 18.8%, 73.1%, and 61.5% respectively. Maximal flow rate significantly increased by 72.0%. Intraprostatic BTX-A injection induces prostate apotosis in dogs and relieves BOO in humans. It is therefore a promising alternative treatment for refractory BOO due to BPH.

References

Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Apr 25, 1991·The New England Journal of Medicine·J Jankovic, M F Brin
Sep 1, 1986·The Journal of Urology·R C BruskewitzT Dørflinger
Aug 22, 1996·The New England Journal of Medicine·P C Walsh
Aug 28, 1998·The Prostate·R DoggweilerR A Schmidt
Jul 6, 2000·British Journal of Pharmacology·W A LauF J Mitchelson
Apr 11, 2003·The Journal of Urology·Christopher P SmithGeorge T Somogyi
Jul 11, 2003·The Journal of Urology·UNKNOWN AUA Practice Guidelines Committee
May 6, 2004·The Journal of Urology·Christopher P Smith, Michael B Chancellor
Feb 14, 2006·The Journal of Urology·Yao-Chi ChuangMichael B Chancellor

❮ Previous
Next ❯

Citations

Oct 26, 2013·International Journal of Oral Science·Xiao-Feng ShanGuang-Yan Yu
May 27, 2009·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Arash M SaemiMark K Plante
Nov 28, 2006·BJU International·Miles A GoldstrawProkar Dasgupta
Jul 22, 2015·Nature Reviews. Urology·Giuseppe MagistroChristian Gratzke
Jun 19, 2013·Neurourology and Urodynamics·Francisco Cruz
Sep 1, 2013·Lower Urinary Tract Symptoms·Yuan-Tso ChengYao-Chi Chuang
Dec 16, 2006·International Journal of Clinical Practice. Supplement·C A ThomasM B Chancellor
Jul 13, 2006·BJU International·Yao-Chi ChuangMichael B Chancellor
Dec 28, 2007·European Urology·Lambertus P W WitteMartin C Michel
Jun 16, 2009·European Urology·Martin C Michel, Christopher R Chapple
Mar 28, 2007·European Urology·Alex Tong Long LinKuang-Kuo Chen
Jun 3, 2008·The Prostate·Mario GardiPierfrancesco Bassi
May 16, 2009·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Shiu-Dong Chung, Hong-Jeng Yu
Sep 10, 2011·Neurourology and Urodynamics·Cristobal MarchalMaximino Redondo
Sep 21, 2010·The Journal of Urology·Adam M BeckerSteven H Selman
Nov 7, 2006·The Journal of Urology·Yao-Chi Chuang, Michael B Chancellor
Oct 10, 2018·Minerva urologica e nefrologica = The Italian journal of urology and nephrology·Riccardo LombardoCosimo De Nunzio
May 23, 2007·The Prostate·Jeffrey N BryanCharles W Caldwell
Sep 9, 2006·Current Urology Reports·Phillip P Smith, Rodney A Appell
Sep 21, 2007·Current Urology Reports·H Henry Lai, Christopher P Smith
Mar 7, 2008·Journal of Neural Transmission·A Apostolidis, C J Fowler
Sep 4, 2008·Current Urology Reports·Fadi Housami, Paul Abrams
Dec 6, 2008·Current Opinion in Urology·Cristian P Ilie, Michael B Chancellor
Dec 20, 2007·Current Opinion in Urology·Arash M Saemi, Mark K Plante
Nov 6, 2009·Current Opinion in Urology·Athanassios Oeconomou, Helmut Madersbacher
May 7, 2010·Current Urology Reports·Henry P GottschRichard E Berger
Nov 26, 2010·Current Opinion in Urology·Emmanuel Chartier-KastlerFrancois Giuliano
Nov 10, 2012·Der Urologe. Ausg. A·L F Arenas da SilvaK-D Sievert
Feb 26, 2013·Der Urologe. Ausg. A·T BschleipferM Oelke
Jan 4, 2013·Scandinavian Journal of Urology·Karl-Erik Andersson
Mar 31, 2017·Pharmacological Reviews·Marco PirazziniCesare Montecucco
Apr 9, 2011·Current Urology Reports·Brian A Parsons, Hashim Hashim
Jan 10, 2019·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·X BiardeauUNKNOWN pour Groupe de recherche appliquée à la pathologie pelvi-périnéale des personnes âgées (GRAPPPA)

❮ Previous
Next ❯

Methods Mentioned

BETA
sedation
biopsy

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.